Charles Nicholas Serhan

This inventor holds 99 USPTO granted patents and 21 published patent applications, plus 4 CIPO patents and 15 EPO patents, primarily in Anti-Inflammatory Mediators (CPC class A61K31-202). Top assignees: The Brigham and Women's Hospital, Inc., Solutex Na, Lcc, University of Southern California. Active years: 1985-2024.

USPTO Granted Patents = 99 (Patent Applications = 21)

% Patents Active = 67.7

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 15 (Patent Applications = 11)

Average Co-Inventor Count = 1.7

ph-index = 17

Forward Citations = 773(Granted Patents)

Forward Citations (Not Self Cited) = 367(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Oceanside, NY (US) (1985)
Brookline, MA (US) (1992)
Boston, MA (US) (1995 - 2002)
Wellsley, MA (US) (2003)
Wellesley, MA (US) (1999 - 2010)
Neddham, MA (US) (2015)
Needham, MA (US) (2003 - 2024)

Company Filing History:

84 out of 1,424

The Brigham and Women's Hospital, Inc.

University of Southern California

University of California

patents

6. 1 out of 1

Resolvyx Pharmaceuticals, Inc.

patent

7. 1 out of 1

Resolvyx Pharmacuticals, Inc.

patent

8. 1 out of 3,690

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

9. 5 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 1985-2024

Loading Chart...

Areas of Expertise:

Proresolving Mediators

Omega-3 Fatty Acids

Resolvins

Neuroprotectin D1

Inflammation Modulation

Cysteinyl-Proresolving Mediators

Lipoxin Analogs

Docosahexaenoic Acid

Vascular Injury

Airway Diseases

Infection Resolution

Aspirin-Triggered Lipid Mediators

99 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11865096 - Oils with anti-inflammatory activity containing natural specialized proresolving mediators and their precursors (2024-01-09),

2. 11833158 - Compositions comprising omega-3 fatty acids, 17-HDHA and 18-HEPE and methods of using same (2023-12-05),

3. 11667598 - N-3 immunoresolvents: structures and actions (2023-06-06),

4. 11592453 - Personalized metabolomic profiling of specialized pro-resolving mediators (2023-02-28),

5. 11559529 - Compositions comprising Omega-3 fatty acids, 17-HDHA and 18-HEPE and methods of using same (2023-01-24),

6. 11555006 - Elucidation of novel 13-series resolvins that increase with atorvastatin and clear infections (2023-01-17),

7. 11519911 - ALX receptor ligands define a biochemical endotype for inflammation-based diseases (2022-12-06),

8. 11285126 - Oils with anti-inflammatory activity containing natural specialized proresolving mediators and their precursors (2022-03-29),

9. 11135228 - Cysteinyl-proresolving mediators that promote resolution of infection and organ protection (2021-10-05),

10. 11077084 - Oils with anti-inflammatory activity containing natural specialized proresolving mediators and their precursors (2021-08-03),

11. 11077083 - Oils with anti-inflammatory activity containing natural Specialized Proresolving Mediators and their precursors (2021-08-03),

12. 11020406 - Compositions comprising omega-3 fatty acids, 17-HDHA and 18-HEPE and methods of using same (2021-06-01),

13. 10653703 - Compositions comprising omega-3 fatty acids, 17-HDHA and 18-HEPE and methods of using same (2020-05-19),

14. 10568858 - Oils with anti-inflammatory activity containing natural specialized proresolving mediators and their precursors (2020-02-25),

15. 10239850 - 14-hydroxy-docosahexaenoic acid compounds (2019-03-26),

Title: The Innovative Journey of Charles Nicholas Serhan

Introduction: Charles Nicholas Serhan, a pioneering inventor based in Needham, MA (US), has made significant contributions to the field of innovations and patents.

Latest Patents: Charles Nicholas Serhan holds several groundbreaking patents in the areas of biotechnology and medical research, focusing on novel approaches to inflammation and immune response modulation.

Career Highlights: With a distinguished career spanning over two decades, Charles Nicholas Serhan has been at the forefront of cutting-edge research, leading to the development of revolutionary technologies that have the potential to transform healthcare practices globally.

Collaborations: Throughout his career, Charles Nicholas Serhan has collaborated with leading research institutions, universities, and biotech companies to further his innovative work, fostering a culture of creativity and excellence in the scientific community.

Conclusion: Charles Nicholas Serhan's relentless pursuit of innovation and his commitment to pushing the boundaries of scientific discovery make him a true visionary in the world of inventions and patents. His work continues to inspire future generations of inventors and researchers to think boldly and strive for excellence in their pursuits.